Aprea Therapeutics, Inc. Common Stock, Share Subscribed but Unissued, Subscriptions Receivable
Aprea Therapeutics, Inc. (APRE) had Common Stock, Share Subscribed but Unissued, Subscriptions Receivable of $500.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable · last filed 2026-05-13
- 2026-03-31: Common Stock, Share Subscribed but Unissued, Subscriptions Receivable $500.00K.
| Period end | Common Stock, Share Subscribed but Unissued, Subscriptions Receivable |
|---|---|
| 2026-03-31 | $500.00K 10-Q · filed 2026-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |